Program Access and Details:

Resources:
DOWNLOADABLE SLIDES and a PROGRAM WORKSHEET. View the Program Materials tab for more information.

Target Audience:
Family physicians, cardiovascular specialists, allied health professionals

This program provides a case-based discussion on SGLT2 inhibition for glycemic control and newer indications such as heart failure prevention, treatment, and management of chronic kidney disease.

This program is NOT accredited.

Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.

Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio. 

This program has been developed by the Canadian Collaborative Research Network, a not-for-profit physician organization, and was supported through an educational grant received from AstraZeneca and Janssen. 

Download program handout/worksheet: 

Participant Handout

Program slides:

This program was developed by the Canadian Collaborative Research Network, a not-for-profit physician organization. A PDF copy of the slides from this program is available for CCRN members of the CCRN website. Visit www.ccrnmd.com/resources to download the materials.